Are You Looking for a Top Momentum Pick? Why Protagonist Therapeutics (PTGX) is a Great Choice
https://www.zacks.com/stock/news/2234835/are-you-looking-for-a-top-momentum-pick-why-protagonist-therapeutics-ptgx-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2234835
Mar 01, 2024 - Does Protagonist Therapeutics (PTGX) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Why ODP Corp. (ODP) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2235341/why-odp-corp-odp-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2235341
Mar 04, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
3 Top-Ranked Stocks to Buy for Big Growth
https://www.zacks.com/commentary/2235614/3-top-ranked-stocks-to-buy-for-big-growth?cid=CS-ZC-FT-investment_ideas-2235614
Mar 04, 2024 - Growth-focused investors have been rewarded handsomely over the last year, enjoying considerable gains. And for those wanting to join the party, these three stocks could be a place to start.
0
5 Top-Ranked ETFs at New Highs Set to Soar Further
https://www.zacks.com/stock/news/2235433/5-top-ranked-etfs-at-new-highs-set-to-soar-further?cid=CS-ZC-FT-etf_news_and_commentary-2235433
Mar 04, 2024 - Given the bullishness, many ETFs, having a solid Zacks ETF Rank #1 (Strong Buy) or 2 (Buy), touched new 52-week high and are expected to soar further.
0
Why Ameriprise Financial Services (AMP) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2235374/why-ameriprise-financial-services-amp-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2235374
Mar 04, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Why Hyatt Hotels (H) is a Top Growth Stock for the Long-Term
https://www.zacks.com/stock/news/2235347/why-hyatt-hotels-h-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2235347
Mar 04, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Are You Looking for a Top Momentum Pick? Why Toyota Motor Corporation (TM) is a Great Choice
https://www.zacks.com/stock/news/2235551/are-you-looking-for-a-top-momentum-pick-why-toyota-motor-corporation-tm-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2235551
Mar 04, 2024 - Does Toyota Motor Corporation (TM) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2235626/akoya-biosciences-akya-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2235626
Mar 04, 2024 - Akoya (AKYA) delivered earnings and revenue surprises of 18.52% and 1.41%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Cadre Holdings, Inc. (CDRE) Tops Q4 Earnings and Revenue Estimates
https://www.zacks.com/stock/news/2236282/cadre-holdings-inc-cdre-tops-q4-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2236282
Mar 05, 2024 - Cadre Holdings, Inc. (CDRE) delivered earnings and revenue surprises of 61.11% and 1.87%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Aeva Technologies, Inc. (AEVA) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2236273/aeva-technologies-inc-aeva-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2236273
Mar 05, 2024 - Aeva Technologies, Inc. (AEVA) delivered earnings and revenue surprises of 7.69% and 1.13%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0